US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neumora Therapeutics, Inc.

1.63

+0.11507.59%

Post-market: 1.630.00000.00%19:38 EDT

Volume:499.11K

Turnover:798.29K

Market Cap:306.44M

PE:-1.33

High:1.64

Open:1.51

Low:1.51

Close:1.52

52wk High:3.65

52wk Low:0.8302

Shares:188.00M

Float Shares:116.00M

Volume Ratio:0.45

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2237

EPS(LYR):-1.4501

ROE:-187.11%

ROA:-73.85%

PB:6.88

PE(LYR):-1.12

Loading ...

Overview Company News Filings

Neumora Therapeutics - Enters Third Amendment to Loan Agreement With K2 Healthventures - SEC Filing

THOMSON REUTERS

Neumora Therapeutics scraps depression drug after two late-stage trial failures

Neumora Therapeutics posts corporate deck on neuroscience drug development pipeline

Neumora reports Phase 3 KOASTAL-2, KOASTAL-3 navacaprant trials miss primary endpoint in depression

Neumora Therapeutics - Expects $2 Mln One-Time Restructuring Costs

THOMSON REUTERS

Neumora Therapeutics Reports Data From Phase 3 Koastal Program and Provides Business and Pipeline Update

THOMSON REUTERS

Neumora Therapeutics - Cash Runway Expected Into Q3 2027

THOMSON REUTERS

Neumora Therapeutics - Nmra-898 Phase 1 Data in Schizophrenia Expected in Second Half 2026

THOMSON REUTERS

Neumora Therapeutics - Discontinues Development of Navacaprant After Phase 3 Koastal-2 and -3 Failure

THOMSON REUTERS

Neumora Therapeutics - Advancing Nmra-511, Nmra-898, and Nmra-215 Programs

THOMSON REUTERS

Neumora Therapeutics - Plans to Initiate Nmra-511 Phase 2B Study by End of 2026

THOMSON REUTERS

Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM

Neumora Shareholders Approve Directors, Auditor and Executive Pay

Neumora Therapeutics shareholders elected three Class III directors at annual meeting

Analysts Conflicted on These Healthcare Names: CVS Health (CVS), Revolution Medicines (RVMD) and Neumora Therapeutics, Inc. (NMRA)

Neumora’s NMRA-323511 Alzheimer’s Agitation Study Reaches Completion, Setting Up the Next Investor Catalyst

Neumora Therapeutics Securities Lawsuit Enters New Procedural Phase as Plaintiffs Prepare New Complaint

Ami Fadia Reiterates Buy on Neumora, Sees Compelling Risk-Reward Ahead of Phase 3 Readouts with Unchanged $8 Price Target

Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NMRA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":1.63,"timestamp":1787342400000,"preClose":1.515,"halted":0,"volume":499105,"hourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.63,"latestTime":"19:38 EDT","volume":1364,"amount":2223.325,"timestamp":1787355505580,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07590759075907591,"floatShares":115999999,"shares":188000000,"eps":-1.223678,"marketStatus":"Market Closed","change":0.115,"latestTime":"08-21 16:00:00 EDT","open":1.51,"high":1.64,"low":1.51,"amount":798291.3460985,"amplitude":0.085809,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.223678,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":1.515,"preHourTrading":{"tag":"盘前","latestPrice":1.53,"preClose":1.515,"latestTime":"09:19 EDT","volume":452,"amount":690.6432988,"timestamp":1787318389604,"change":0.015,"changeRate":0.009901,"amplitude":0.012739},"postHourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.63,"latestTime":"19:38 EDT","volume":1364,"amount":2223.325,"timestamp":1787355505580,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.453570099750214,"impliedVol":0.1949,"impliedVolPercentile":0.0159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","floatShares":115999999,"roa":"-73.85%","roe":"-187.11%","lyrEps":-1.450067,"volumeRatio":0.453570099750214,"shares":188000000,"dividePrice":0,"high":1.64,"amplitude":0.085809,"preClose":1.515,"low":1.51,"week52Low":0.83015,"pbRate":"6.88","week52High":3.65,"institutionHeld":0,"latestPrice":1.63,"eps":-1.223678,"divideRate":0,"volume":499105,"delay":0,"ttmEps":-1.223678,"open":1.51,"prevYearClose":1.79,"prevWeekClose":1.6,"prevMonthClose":1.61,"prevQuarterClose":1.7,"fiveDayClose":1.6,"twentyDayClose":1.49,"sixtyDayClose":1.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"NMRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.23,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2026-05-07","symbol":"NMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2026-03-30","symbol":"NMRA","fiscalQuarterEnding":"2025/12","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-11-06","symbol":"NMRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-08-06","symbol":"NMRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4444,"hold":0.1111,"sell":0.1111,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":9,"updateTime":1771387200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMRA","date":"2026-08-21","current":-1.33205,"percent":0.680339,"low":-19.620035,"twenty":-8.610207,"median":-1.734908,"eighty":-1.069031,"high":-0.385538,"avg":-4.839955,"sd":4.928367,"marketCap":284662306},"quantilePoints":[{"date":"2023-09-15","current":-19.620035,"twenty":-19.620035,"median":-19.620035,"eighty":-19.620035,"marketCap":2583134632},{"date":"2023-09-22","current":-12.753675,"twenty":-18.754446,"median":-15.453663,"eighty":-12.753675,"marketCap":1679123396},{"date":"2023-09-28","current":-13.691957,"twenty":-17.415667,"median":-13.628246,"eighty":-12.772209,"marketCap":1802655635},{"date":"2023-10-05","current":-13.813351,"twenty":-16.65135,"median":-13.723658,"eighty":-12.773914,"marketCap":1818638110},{"date":"2023-10-13","current":-11.180579,"twenty":-14.994038,"median":-13.691957,"eighty":-12.763183,"marketCap":1472012710},{"date":"2023-10-20","current":-11.493728,"twenty":-13.94093,"median":-13.080265,"eighty":-11.639864,"marketCap":1513241282},{"date":"2023-10-27","current":-14.254079,"twenty":-14.080107,"median":-13.080265,"eighty":-11.690896,"marketCap":1876663508},{"date":"2023-11-03","current":-10.734234,"twenty":-13.848145,"median":-12.776843,"eighty":-11.493728,"marketCap":1667466680},{"date":"2023-11-10","current":-10.420012,"twenty":-13.826354,"median":-12.7442,"eighty":-11.403032,"marketCap":1618655149},{"date":"2023-11-17","current":-11.79624,"twenty":-13.813351,"median":-12.154821,"eighty":-11.403032,"marketCap":1832439792},{"date":"2023-11-24","current":-11.717599,"twenty":-13.766958,"median":-11.806071,"eighty":-11.438475,"marketCap":1820223526},{"date":"2023-12-01","current":-12.041995,"twenty":-13.704638,"median":-11.815901,"eighty":-11.48267,"marketCap":1870615621},{"date":"2023-12-08","current":-12.26809,"twenty":-13.59002,"median":-11.825731,"eighty":-11.493283,"marketCap":1905737383},{"date":"2023-12-15","current":-14.381583,"twenty":-13.717318,"median":-11.894542,"eighty":-11.493728,"marketCap":2234049513},{"date":"2023-12-22","current":-13.75245,"twenty":-13.821153,"median":-12.041995,"eighty":-11.521564,"marketCap":2136319390},{"date":"2023-12-29","current":-16.848963,"twenty":-14.008036,"median":-12.137729,"eighty":-11.563317,"marketCap":2617334836},{"date":"2024-01-05","current":-16.111698,"twenty":-14.24211,"median":-12.26809,"eighty":-11.573312,"marketCap":2502807349},{"date":"2024-01-12","current":-14.991056,"twenty":-14.660761,"median":-12.728927,"eighty":-11.585874,"marketCap":2328725569},{"date":"2024-01-19","current":-14.411074,"twenty":-14.428768,"median":-12.751722,"eighty":-11.613398,"marketCap":2238630612},{"date":"2024-01-26","current":-14.843603,"twenty":-15.020547,"median":-12.776843,"eighty":-11.648787,"marketCap":2305820071},{"date":"2024-02-02","current":-14.991056,"twenty":-15.264335,"median":-13.370218,"eighty":-11.652719,"marketCap":2328725569},{"date":"2024-02-09","current":-17.1537,"twenty":-15.346909,"median":-13.691957,"eighty":-11.671529,"marketCap":2664672864},{"date":"2024-02-16","current":-18.490607,"twenty":-15.539581,"median":-13.783396,"eighty":-11.691031,"marketCap":2872349373},{"date":"2024-02-23","current":-18.500437,"twenty":-15.932789,"median":-13.819852,"eighty":-11.69454,"marketCap":2873876407},{"date":"2024-03-01","current":-17.330643,"twenty":-16.668088,"median":-13.939224,"eighty":-11.709735,"marketCap":2692159461},{"date":"2024-03-08","current":-12.297819,"twenty":-16.990518,"median":-13.97363,"eighty":-11.717599,"marketCap":2901363004},{"date":"2024-03-15","current":-10.189453,"twenty":-16.81554,"median":-13.826354,"eighty":-11.69454,"marketCap":2403946708},{"date":"2024-03-22","current":-9.414974,"twenty":-16.668088,"median":-13.783396,"eighty":-11.650753,"marketCap":2221227691},{"date":"2024-03-28","current":-8.492333,"twenty":-16.613039,"median":-13.722203,"eighty":-11.579976,"marketCap":2003553733},{"date":"2024-04-05","current":-9.246609,"twenty":-16.364935,"median":-13.534996,"eighty":-11.491504,"marketCap":2181506166},{"date":"2024-04-12","current":-9.435178,"twenty":-16.111698,"median":-12.865966,"eighty":-11.216259,"marketCap":2225994275},{"date":"2024-04-19","current":-7.105005,"twenty":-15.954415,"median":-12.753675,"eighty":-10.606446,"marketCap":1676248365},{"date":"2024-04-26","current":-6.123304,"twenty":-15.846283,"median":-12.728927,"eighty":-10.162515,"marketCap":1444640411},{"date":"2024-05-03","current":-6.231441,"twenty":-15.669339,"median":-12.297819,"eighty":-9.792112,"marketCap":1470152824},{"date":"2024-05-10","current":-6.135514,"twenty":-15.610358,"median":-12.155389,"eighty":-9.435178,"marketCap":1558549450},{"date":"2024-05-17","current":-6.047595,"twenty":-15.433415,"median":-12.120637,"eighty":-9.273547,"marketCap":1536216091},{"date":"2024-05-24","current":-5.846636,"twenty":-15.423584,"median":-11.91675,"eighty":-8.957021,"marketCap":1485168412},{"date":"2024-05-31","current":-6.085275,"twenty":-15.399992,"median":-11.884712,"eighty":-8.469435,"marketCap":1545787530},{"date":"2024-06-07","current":-6.235993,"twenty":-15.362637,"median":-11.806071,"eighty":-7.09423,"marketCap":1584073290},{"date":"2024-06-14","current":-6.248553,"twenty":-15.342977,"median":-11.75692,"eighty":-6.904314,"marketCap":1587263770},{"date":"2024-06-21","current":-5.557759,"twenty":-15.335113,"median":-11.717599,"eighty":-6.419582,"marketCap":1411787373},{"date":"2024-06-28","current":-5.777557,"twenty":-15.335113,"median":-11.707769,"eighty":-6.279953,"marketCap":1467620772},{"date":"2024-07-05","current":-6.129234,"twenty":-15.228947,"median":-11.690896,"eighty":-6.264891,"marketCap":1556954210},{"date":"2024-07-12","current":-7.253346,"twenty":-15.12278,"median":-11.653703,"eighty":-6.277441,"marketCap":1842502165},{"date":"2024-07-15","current":-6.939348,"twenty":-15.110984,"median":-11.648787,"eighty":-6.278697,"marketCap":1762740166},{"date":"2024-08-02","current":-7.931581,"twenty":-15.099188,"median":-11.648787,"eighty":-6.279953,"marketCap":2014788082},{"date":"2024-08-09","current":-6.56038,"twenty":-15.040207,"median":-11.579976,"eighty":-6.279953,"marketCap":1798711865},{"date":"2024-08-16","current":-6.881395,"twenty":-14.991056,"median":-11.493728,"eighty":-6.279953,"marketCap":1886727125},{"date":"2024-08-23","current":-6.712133,"twenty":-14.991056,"median":-11.447336,"eighty":-6.393648,"marketCap":1840319079},{"date":"2024-08-30","current":-6.54287,"twenty":-14.922244,"median":-11.299816,"eighty":-6.436952,"marketCap":1793911032},{"date":"2024-09-06","current":-6.297731,"twenty":-14.859331,"median":-10.957407,"eighty":-6.374465,"marketCap":1726699379},{"date":"2024-09-13","current":-6.904742,"twenty":-14.68632,"median":-10.606446,"eighty":-6.374465,"marketCap":1893128235},{"date":"2024-09-20","current":-7.430039,"twenty":-14.481851,"median":-10.304733,"eighty":-6.410301,"marketCap":2037153206},{"date":"2024-09-27","current":-7.634321,"twenty":-14.416972,"median":-9.973946,"eighty":-6.432454,"marketCap":2093162917},{"date":"2024-10-04","current":-7.905725,"twenty":-14.387481,"median":-9.835887,"eighty":-6.454177,"marketCap":2167575819},{"date":"2024-10-11","current":-8.988421,"twenty":-14.365855,"median":-9.536197,"eighty":-6.471402,"marketCap":2464427288},{"date":"2024-10-18","current":-9.898936,"twenty":-14.275648,"median":-9.492422,"eighty":-6.494727,"marketCap":2714070572},{"date":"2024-10-25","current":-7.587628,"twenty":-14.23812,"median":-9.435178,"eighty":-6.5109,"marketCap":2080360698},{"date":"2024-10-31","current":-7.126534,"twenty":-14.186945,"median":-9.414974,"eighty":-6.517189,"marketCap":1953938778},{"date":"2024-11-08","current":-7.599301,"twenty":-14.11026,"median":-9.329429,"eighty":-6.519524,"marketCap":2083561252},{"date":"2024-11-15","current":-6.430581,"twenty":-14.036864,"median":-9.246609,"eighty":-6.508113,"marketCap":1888648838},{"date":"2024-11-22","current":-5.330396,"twenty":-14.008036,"median":-9.078889,"eighty":-6.434404,"marketCap":1565526710},{"date":"2024-11-29","current":-5.467919,"twenty":-13.980511,"median":-8.972721,"eighty":-6.336098,"marketCap":1605916976},{"date":"2024-12-06","current":-5.313893,"twenty":-13.902792,"median":-8.614876,"eighty":-6.276185,"marketCap":1560679878},{"date":"2024-12-13","current":-5.819979,"twenty":-13.839429,"median":-8.495238,"eighty":-6.248553,"marketCap":1709316057},{"date":"2024-12-20","current":-5.775971,"twenty":-13.821153,"median":-8.377845,"eighty":-6.222869,"marketCap":1696391172},{"date":"2024-12-27","current":-6.238049,"twenty":-13.812967,"median":-8.200475,"eighty":-6.175381,"marketCap":1832102465},{"date":"2025-01-03","current":-1.083682,"twenty":-13.811432,"median":-8.147945,"eighty":-6.157876,"marketCap":318275296},{"date":"2025-01-10","current":-1.303719,"twenty":-13.766574,"median":-7.931581,"eighty":-6.140538,"marketCap":382899721},{"date":"2025-01-17","current":-1.193701,"twenty":-13.753032,"median":-7.891133,"eighty":-6.119668,"marketCap":350587508},{"date":"2025-01-24","current":-1.1882,"twenty":-13.716154,"median":-7.812392,"eighty":-6.085275,"marketCap":348971898},{"date":"2025-01-31","current":-1.056178,"twenty":-13.615504,"median":-7.634321,"eighty":-6.067691,"marketCap":310197242},{"date":"2025-02-07","current":-1.07268,"twenty":-13.546812,"median":-7.564281,"eighty":-5.978405,"marketCap":315044074},{"date":"2025-02-14","current":-0.929656,"twenty":-13.337262,"median":-7.53602,"eighty":-5.966304,"marketCap":273038198},{"date":"2025-02-21","current":-0.940658,"twenty":-13.1053,"median":-7.470895,"eighty":-5.920328,"marketCap":276269419},{"date":"2025-02-28","current":-0.852643,"twenty":-12.883791,"median":-7.424202,"eighty":-5.847483,"marketCap":250419649},{"date":"2025-03-07","current":-1.009931,"twenty":-12.773914,"median":-7.253346,"eighty":-5.800175,"marketCap":246207962},{"date":"2025-03-14","current":-0.930199,"twenty":-12.763183,"median":-7.144044,"eighty":-5.763741,"marketCap":226770492},{"date":"2025-03-21","current":-0.770737,"twenty":-12.752113,"median":-7.105005,"eighty":-5.687956,"marketCap":187895550},{"date":"2025-03-28","current":-0.730871,"twenty":-12.743752,"median":-7.036301,"eighty":-5.574632,"marketCap":178176815},{"date":"2025-04-04","current":-0.564099,"twenty":-12.730087,"median":-6.998128,"eighty":-5.417311,"marketCap":137520105},{"date":"2025-04-11","current":-0.476129,"twenty":-12.580434,"median":-6.945391,"eighty":-5.374404,"marketCap":116074096},{"date":"2025-04-17","current":-0.41859,"twenty":-12.352677,"median":-6.926527,"eighty":-5.321594,"marketCap":102046721},{"date":"2025-04-25","current":-0.497989,"twenty":-12.291873,"median":-6.904742,"eighty":-1.375231,"marketCap":121403202},{"date":"2025-05-02","current":-0.511809,"twenty":-12.245663,"median":-6.881395,"eighty":-1.223405,"marketCap":124772347},{"date":"2025-05-09","current":-0.423699,"twenty":-12.15573,"median":-6.846375,"eighty":-1.1893,"marketCap":103292222},{"date":"2025-05-16","current":-0.417316,"twenty":-12.148314,"median":-6.834702,"eighty":-1.12879,"marketCap":107691766},{"date":"2025-05-23","current":-0.449909,"twenty":-12.121955,"median":-6.75723,"eighty":-1.07488,"marketCap":116102658},{"date":"2025-05-30","current":-0.450473,"twenty":-12.120637,"median":-6.747152,"eighty":-1.061679,"marketCap":116248231},{"date":"2025-06-06","current":-0.507762,"twenty":-12.041995,"median":-6.685868,"eighty":-1.033834,"marketCap":131031991},{"date":"2025-06-13","current":-0.562731,"twenty":-11.924033,"median":-6.5954,"eighty":-0.989998,"marketCap":145217284},{"date":"2025-06-20","current":-0.488895,"twenty":-11.91238,"median":-6.57789,"eighty":-0.951354,"marketCap":126163379},{"date":"2025-06-27","current":-0.501055,"twenty":-11.897527,"median":-6.552046,"eighty":-0.939895,"marketCap":129301288},{"date":"2025-07-03","current":-0.51497,"twenty":-11.882746,"median":-6.531197,"eighty":-0.932192,"marketCap":132892092},{"date":"2025-07-11","current":-0.664396,"twenty":-11.845391,"median":-6.513687,"eighty":-0.915408,"marketCap":171452797},{"date":"2025-07-18","current":-1.071809,"twenty":-11.813935,"median":-6.466558,"eighty":-0.901766,"marketCap":276588946},{"date":"2025-07-25","current":-1.435347,"twenty":-11.800172,"median":-6.430581,"eighty":-0.91143,"marketCap":370402741},{"date":"2025-08-01","current":-1.228506,"twenty":-11.772648,"median":-6.345689,"eighty":-0.913154,"marketCap":317025927},{"date":"2025-08-08","current":-1.05869,"twenty":-11.733327,"median":-6.279953,"eighty":-0.915408,"marketCap":266884071},{"date":"2025-08-15","current":-1.015014,"twenty":-11.717599,"median":-6.27111,"eighty":-0.917957,"marketCap":255873774},{"date":"2025-08-22","current":-1.053558,"twenty":-11.711701,"median":-6.248553,"eighty":-0.922507,"marketCap":265590500},{"date":"2025-08-29","current":-1.130648,"twenty":-11.697847,"median":-6.240161,"eighty":-0.927824,"marketCap":285023951},{"date":"2025-09-05","current":-1.047134,"twenty":-11.691098,"median":-6.234271,"eighty":-0.929873,"marketCap":263971046},{"date":"2025-09-12","current":-1.066407,"twenty":-11.688352,"median":-6.217154,"eighty":-0.931528,"marketCap":268829408},{"date":"2025-09-19","current":-1.00859,"twenty":-11.674168,"median":-6.167847,"eighty":-0.932308,"marketCap":254254320},{"date":"2025-09-26","current":-1.092103,"twenty":-11.654686,"median":-6.150338,"eighty":-0.934175,"marketCap":275307225},{"date":"2025-10-03","current":-1.143496,"twenty":-11.648787,"median":-6.138654,"eighty":-0.935832,"marketCap":288262860},{"date":"2025-10-10","current":-1.252707,"twenty":-11.625195,"median":-6.129234,"eighty":-0.937276,"marketCap":315793582},{"date":"2025-10-17","current":-1.143496,"twenty":-11.585874,"median":-6.098338,"eighty":-0.939018,"marketCap":288262860},{"date":"2025-10-24","current":-1.483976,"twenty":-11.573312,"median":-6.085275,"eighty":-0.940658,"marketCap":374093936},{"date":"2025-10-31","current":-1.882272,"twenty":-11.535481,"median":-6.072715,"eighty":-0.944448,"marketCap":474500101},{"date":"2025-11-07","current":-1.768195,"twenty":-11.493728,"median":-6.047595,"eighty":-0.950132,"marketCap":417819201},{"date":"2025-11-14","current":-1.902139,"twenty":-11.492838,"median":-5.97813,"eighty":-0.950743,"marketCap":449469716},{"date":"2025-11-21","current":-1.668791,"twenty":-11.473837,"median":-5.972235,"eighty":-0.95386,"marketCap":394330309},{"date":"2025-11-28","current":-1.583937,"twenty":-11.438475,"median":-5.963003,"eighty":-0.958453,"marketCap":374279615},{"date":"2025-12-05","current":-1.608686,"twenty":-11.3991,"median":-5.921482,"eighty":-0.963621,"marketCap":380127734},{"date":"2025-12-12","current":-1.488688,"twenty":-11.349949,"median":-5.869128,"eighty":-0.966191,"marketCap":351772572},{"date":"2025-12-19","current":-1.236978,"twenty":-11.209123,"median":-5.84706,"eighty":-0.976733,"marketCap":292294118},{"date":"2025-12-26","current":-1.301703,"twenty":-11.180579,"median":-5.82548,"eighty":-0.977791,"marketCap":307588578},{"date":"2026-01-02","current":-1.28732,"twenty":-10.823503,"median":-5.782265,"eighty":-0.97889,"marketCap":304189809},{"date":"2026-01-09","current":-1.675673,"twenty":-10.734234,"median":-5.771277,"eighty":-0.987831,"marketCap":395956567},{"date":"2026-01-16","current":-1.531839,"twenty":-10.632004,"median":-5.730809,"eighty":-0.990132,"marketCap":361968879},{"date":"2026-01-23","current":-1.510263,"twenty":-10.51228,"median":-5.690707,"eighty":-0.994023,"marketCap":356870726},{"date":"2026-01-30","current":-1.474305,"twenty":-10.431808,"median":-5.626838,"eighty":-0.999937,"marketCap":348373804},{"date":"2026-02-06","current":-1.409579,"twenty":-10.281677,"median":-5.512839,"eighty":-1.00602,"marketCap":333079344},{"date":"2026-02-13","current":-2.337313,"twenty":-10.17329,"median":-5.423912,"eighty":-1.009395,"marketCap":552299933},{"date":"2026-02-20","current":-2.502722,"twenty":-10.087087,"median":-5.390906,"eighty":-1.011964,"marketCap":591385774},{"date":"2026-02-27","current":-2.553064,"twenty":-9.944314,"median":-5.374404,"eighty":-1.018277,"marketCap":603281465},{"date":"2026-03-06","current":-2.157519,"twenty":-9.899493,"median":-5.330396,"eighty":-1.027437,"marketCap":509815323},{"date":"2026-03-13","current":-2.258203,"twenty":-9.891226,"median":-5.316643,"eighty":-1.03397,"marketCap":533606704},{"date":"2026-03-20","current":-1.848275,"twenty":-9.844641,"median":-2.553064,"eighty":-1.034185,"marketCap":436741793},{"date":"2026-03-27","current":-1.790741,"twenty":-9.769472,"median":-2.506318,"eighty":-1.034236,"marketCap":423146718},{"date":"2026-04-02","current":-1.605828,"twenty":-9.718546,"median":-2.484743,"eighty":-1.034286,"marketCap":380465575},{"date":"2026-04-10","current":-1.598144,"twenty":-9.645471,"median":-2.437997,"eighty":-1.035523,"marketCap":378645165},{"date":"2026-04-17","current":-1.536677,"twenty":-9.606931,"median":-2.340909,"eighty":-1.040518,"marketCap":364081890},{"date":"2026-04-24","current":-1.719486,"twenty":-9.518687,"median":-2.301354,"eighty":-1.04071,"marketCap":407394409},{"date":"2026-05-01","current":-1.904543,"twenty":-9.445953,"median":-2.229437,"eighty":-1.041995,"marketCap":451239547},{"date":"2026-05-08","current":-1.495876,"twenty":-9.432484,"median":-2.171903,"eighty":-1.047134,"marketCap":354414867},{"date":"2026-05-15","current":-1.618279,"twenty":-9.420361,"median":-2.157519,"eighty":-1.047134,"marketCap":359895509},{"date":"2026-05-22","current":-1.519703,"twenty":-9.409586,"median":-2.064027,"eighty":-1.047134,"marketCap":337972940},{"date":"2026-05-29","current":-1.544347,"twenty":-9.388035,"median":-2.022348,"eighty":-1.047134,"marketCap":343453582},{"date":"2026-06-05","current":-1.437557,"twenty":-9.385312,"median":-1.929745,"eighty":-1.050677,"marketCap":319704133},{"date":"2026-06-12","current":-1.48298,"twenty":-9.273547,"median":-1.902139,"eighty":-1.053558,"marketCap":329805954},{"date":"2026-06-18","current":-1.274697,"twenty":-9.262772,"median":-1.884704,"eighty":-1.052982,"marketCap":283484893},{"date":"2026-06-26","current":-1.258034,"twenty":-9.249303,"median":-1.881168,"eighty":-1.053558,"marketCap":279779208},{"date":"2026-07-02","current":-1.349679,"twenty":-9.177916,"median":-1.861064,"eighty":-1.05513,"marketCap":300160475},{"date":"2026-07-10","current":-1.374673,"twenty":-9.115941,"median":-1.805124,"eighty":-1.057685,"marketCap":305719002},{"date":"2026-07-17","current":-1.333016,"twenty":-9.073636,"median":-1.796333,"eighty":-1.060483,"marketCap":296454790},{"date":"2026-07-24","current":-1.299691,"twenty":-9.014102,"median":-1.790741,"eighty":-1.061679,"marketCap":289043420},{"date":"2026-07-31","current":-1.374673,"twenty":-8.975861,"median":-1.781172,"eighty":-1.06357,"marketCap":305719002},{"date":"2026-08-07","current":-1.366342,"twenty":-8.932776,"median":-1.776358,"eighty":-1.066407,"marketCap":303866160},{"date":"2026-08-14","current":-1.441324,"twenty":-8.783796,"median":-1.768195,"eighty":-1.066716,"marketCap":320541742},{"date":"2026-08-21","current":-1.338045,"twenty":-8.610207,"median":-1.734908,"eighty":-1.069031,"marketCap":284662306}],"updateTime":1787472412609},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMRA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643031282","title":"Neumora Therapeutics - Enters Third Amendment to Loan Agreement With K2 Healthventures - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643031282","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643031282?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:16","pubTimestamp":1781525796,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nFWN42N0K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643720338","title":"Neumora Therapeutics scraps depression drug after two late-stage trial failures","url":"https://stock-news.laohu8.com/highlight/detail?id=2643720338","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643720338?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:04","pubTimestamp":1781525067,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics scraps depression drug after two late-stage trial failuresJune 15  - Neumora Therapeutics NMRA.O said on Monday it would stop developing its depression drug after two late-stage trials failed to meet their main goals.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4N42N127:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643396203","title":"Neumora Therapeutics posts corporate deck on neuroscience drug development pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2643396203","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643396203?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:04","pubTimestamp":1781525043,"startTime":"0","endTime":"0","summary":"Neumora outlined three core franchises spanning neurodegenerative, neuropsychiatric, and metabolic disease, led by NMRA-511, NMRA-898, and NMRA-215.NMRA-511 for agitation in Alzheimer’s disease: Phase 1b signal-seeking study showed Cohen’s d 0.32-0.34 in the overall NPI-AA ≥4 population.Elevated-anxiety subgroup  showed larger effects for NMRA-511, including CMAI Cohen’s d 0.51-0.64; aggressive-behaviors factor 0.82-1.1.Near-term catalysts: NMRA-511 multiple-ascending-dose data in 2H 2026; NMRA-898 Phase 1 data in 2H 2026; NMRA-511 Phase 2 start in 1Q 2027.Cash runway projected to support operations into 3Q 2027; NMRA-215 clinical program initiation targeted for 1Q 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neumora Therapeuti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL326031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643038442","title":"Neumora reports Phase 3 KOASTAL-2, KOASTAL-3 navacaprant trials miss primary endpoint in depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2643038442","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643038442?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:03","pubTimestamp":1781525008,"startTime":"0","endTime":"0","summary":"Neumora reported Phase 3 KOASTAL-2 and KOASTAL-3 results showing navacaprant missed key depression trial goals, prompting a program halt.Management shifted focus to other pipeline assets, with new readouts scheduled for 2H 2026 and plans to start additional studies by end-2026.A 35% workforce reduction targets about USD 10 million in annualized savings, with about USD 2 million in one-time restructuring costs.Cash runway projected into Q3 2027, supporting multiple planned clinical milestones.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL80cnxS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4007","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","LU0314104364.USD","LU2095319765.USD","BK4585","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BGHQF748.EUR","NMRA","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643520801","title":"Neumora Therapeutics - Expects $2 Mln One-Time Restructuring Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2643520801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643520801?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:00","pubTimestamp":1781524803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA6KL6MJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643320804","title":"Neumora Therapeutics Reports Data From Phase 3 Koastal Program and Provides Business and Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2643320804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643320804?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:00","pubTimestamp":1781524803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA6KL6MJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643208064","title":"Neumora Therapeutics - Cash Runway Expected Into Q3 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2643208064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643208064?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:00","pubTimestamp":1781524803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA6KL6MJ:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643208052","title":"Neumora Therapeutics - Nmra-898 Phase 1 Data in Schizophrenia Expected in Second Half 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643208052","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643208052?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:00","pubTimestamp":1781524803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA6KL6MJ:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643208050","title":"Neumora Therapeutics - Discontinues Development of Navacaprant After Phase 3 Koastal-2 and -3 Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2643208050","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643208050?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:00","pubTimestamp":1781524803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA6KL6MJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643120805","title":"Neumora Therapeutics - Advancing Nmra-511, Nmra-898, and Nmra-215 Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2643120805","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643120805?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:00","pubTimestamp":1781524803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA6KL6MJ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643095208","title":"Neumora Therapeutics - Plans to Initiate Nmra-511 Phase 2B Study by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643095208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643095208?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:00","pubTimestamp":1781524803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA6KL6MJ:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203384","title":"Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203384","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203384?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:00","pubTimestamp":1781524800,"startTime":"0","endTime":"0","summary":"Navacaprant did not achieve the primary endpoint in KOASTAL-2 or -3; Company to discontinue development of navacaprant Advancing potential best-in-class programs with NMRA-511 in Alzheimer’s disease a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/15/3311713/0/en/Neumora-Therapeutics-Reports-Data-from-Phase-3-KOASTAL-Program-and-Provides-Business-and-Pipeline-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFB","BK4007","NMRA","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643208749","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2643208749","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643208749?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:55","pubTimestamp":1781524500,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:55 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nAQN2M3IR0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639677706","title":"Neumora Shareholders Approve Directors, Auditor and Executive Pay","url":"https://stock-news.laohu8.com/highlight/detail?id=2639677706","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639677706?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:58","pubTimestamp":1780088297,"startTime":"0","endTime":"0","summary":"An update from Neumora Therapeutics, Inc. ( ($NMRA) ) is now available. At its May 27, 2026 annual meeting of stockholders, Neumora Therapeutics, I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neumora-shareholders-approve-directors-auditor-and-executive-pay?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neumora-shareholders-approve-directors-auditor-and-executive-pay?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672229","title":"Neumora Therapeutics shareholders elected three Class III directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672229","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672229?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:07","pubTimestamp":1780085266,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics held its annual shareholder meeting on May 27, 2026.Shareholders backed the board’s director slate.Investors supported holding the advisory vote on executive pay on an annual schedule; the company will run that vote every year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neumora Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL4G1StW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638502333","title":"Analysts Conflicted on These Healthcare Names: CVS Health (CVS), Revolution Medicines (RVMD) and Neumora Therapeutics, Inc. (NMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638502333","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638502333?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:20","pubTimestamp":1779880857,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVS Health (CVS), Revolution Medicines (RVMD) and Neumora Therape...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cvs-health-cvs-revolution-medicines-rvmd-and-neumora-therapeutics-inc-nmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cvs-health-cvs-revolution-medicines-rvmd-and-neumora-therapeutics-inc-nmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVS","IE00BSNM7G36.USD","IE0002270589.USD","LU0006061336.USD","IE0009355771.USD","LU0109394709.USD","IE00BKVL7J92.USD","BK4139","BK4007","LU0072461881.USD","NMRA","IE00BJT1NW94.SGD","LU0061475181.USD","LU0208291251.USD","LU0320765489.SGD","LU0889565916.HKD","LU0162691827.USD","BK4504","HCSG","BK4137","IE0002141913.USD","LU1059921491.USD","LU0211331839.USD","IE00B4R5TH58.HKD","LU2125909593.SGD","LU0432979614.USD","BK4581","BK4550","IE00B2B36J28.USD","LU0128526141.USD","LU1699723380.USD","IE00BFTCPJ56.SGD","LU2125909247.SGD","RVMD","IE00BJJMRZ35.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0070302665.USD","XBI","LU1571399168.USD","XLV","LU0320765992.SGD","BK4196","IE00B7SZLL34.SGD","BK4585","LU1923622614.USD","LU1983299246.USD","LU2433249047.HKD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637734504","title":"Neumora’s NMRA-323511 Alzheimer’s Agitation Study Reaches Completion, Setting Up the Next Investor Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2637734504","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637734504?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:32","pubTimestamp":1779467550,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. ($NMRA) announced an update on their ongoing clinical study. The Phase 1b study, officially titled A Phase 1b, Randomize...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neumoras-nmra-323511-alzheimers-agitation-study-reaches-completion-setting-up-the-next-investor-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neumoras-nmra-323511-alzheimers-agitation-study-reaches-completion-setting-up-the-next-investor-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636058400","title":"Neumora Therapeutics Securities Lawsuit Enters New Procedural Phase as Plaintiffs Prepare New Complaint","url":"https://stock-news.laohu8.com/highlight/detail?id=2636058400","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636058400?lang=en_us&edition=fundamental","pubTime":"2026-05-19 02:24","pubTimestamp":1779128649,"startTime":"0","endTime":"0","summary":"Investors following the securities lawsuit against Neumora Therapeutics (NMRA) are facing another procedural turn after a federal judge denied the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/neumora-therapeutics-securities-lawsuit-enters-new-procedural-phase-as-plaintiffs-prepare-new-complaint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/neumora-therapeutics-securities-lawsuit-enters-new-procedural-phase-as-plaintiffs-prepare-new-complaint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","NMRA","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635711944","title":"Ami Fadia Reiterates Buy on Neumora, Sees Compelling Risk-Reward Ahead of Phase 3 Readouts with Unchanged $8 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2635711944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635711944?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:15","pubTimestamp":1778757323,"startTime":"0","endTime":"0","summary":"Analyst Ami Fadia from Needham maintained a Buy rating on Neumora Therapeutics, Inc. and keeping the price target at $8.00. Ami Fadia has given his...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ami-fadia-reiterates-buy-on-neumora-sees-compelling-risk-reward-ahead-of-phase-3-readouts-with-unchanged-8-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ami-fadia-reiterates-buy-on-neumora-sees-compelling-risk-reward-ahead-of-phase-3-readouts-with-unchanged-8-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635405182","title":"Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2635405182","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635405182?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., May  12, 2026  (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that targ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293381/0/en/Neumora-Therapeutics-to-Participate-in-2026-RBC-Capital-Markets-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","LU0128525929.USD","BK4137","HCSG","LU0310800379.SGD","XLV","LABU","BK4207","LU1267930573.SGD","LU0708994859.HKD","XBI","BK4588","BK4585","NMRA","LU0029864427.USD","BK4007","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":94,"code":"91000000","status":"200"}]}}